Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
National University Corporation Kochi University is currently prosecuting a portfolio in the Biotechnology & Pharmaceuticals technology area. There are 2 pending office actions distributed across 2 distinct examiners. This distribution suggests that each pending matter is being evaluated independently by a different official. The workload is spread across 2 distinct art units, which indicates that the applicant is pursuing innovations in multiple specialized fields within biotechnology.
BRANDSEN, BENJAMIN MICHAEL is the busiest examiner for this portfolio, with 1 pending office action currently assigned to him. This means the other 1 pending office action is being handled by the second of the 2 distinct examiners. The presence of 2 distinct art units suggests a diverse technical range for the 2 pending office actions. Practitioners must manage two separate examination tracks, each with its own examiner and art unit. The 2 pending office actions represent the current focus of the university's efforts to secure patent protection in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRANDSEN, BENJAMIN MICHAEL | 1 | 60.9% | +21.7% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | — |
| 18025312 | FLUORESCENT DYE AND METHOD FOR DETECTING TUMOR CELLS | DONOHUE, SEAN R | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | 1693 | §101§102§112DP | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18025312 | FLUORESCENT DYE AND METHOD FOR DETECTING TUMOR CELLS | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | — | Pending | Oct 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational University Corporation Kochi University has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Benjamin Michael Brandsen has the most, with 1 of National University Corporation Kochi University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
